Lancet Oncol 20 (3): 339-351, 2019.[PUBMED Abstract] Coleman R, Finkelstein DM, Barrios C, et al.: Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.
Lancet Oncol 21 (1): 60-72, 2020.[PUBMED Abstract] Friedl TWP, Fehm T, MÃ¼ller V, et al.: Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial.
JAMA Oncol 7 (8): 1149-1157, 2021.[PUBMED Abstract] Desnoyers A, Amir E, Tannock IF: Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?